Biotech Company Seeks FDA Approval For Psilocybin-IBS Treatment

Trip Therapeutics announced On Wednesday, the company announced that it had submitted an investigational new drug (IND) to the U.S. Food and Drug Administration (FDA) for a Phase 2a clinical…

Read More

Biotech Firm Launches Trial To Study LSD As Treatment For Anxiety

The New York-based biotech company has begun a clinical trial studying LSD as a treatment for anxiety, and announced last week that it was giving hallucinogenic drugs to patients enrolled…

Read More